Bortezomib/Cyclophosphamide/Dexamethasone/Rituximab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bortezomib, cyclophosphamide, dexamethasone, and rituximab that may be used in the treatment of Waldenstrom macroglobulinemia (WM) and lymphoplasmacytic lymphoma (LPL).

**Synonyms:** - B-DRC - B-DRC Regimen - Bortezomib-Cyclophosphamide-Dexamethasone-Rituximab - Bortezomib-DRC Regimen - Bortezomib/Cyclophosphamide/Dexamethasone Plus Rituximab - Bortezomib/Cyclophosphamide/Dexamethasone/Rituximab - Velcade/Cytoxan/Decadron/Rituxan